FDA Assessing QT Study Designs With Clinical Trial Simulations
FDA hopes to use clinical trial simulations to develop study designs to more accurately predict drugs' QT prolongation risk
FDA hopes to use clinical trial simulations to develop study designs to more accurately predict drugs' QT prolongation risk